Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2349)
  2. Meeting Abstract (1870)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (100)
  6. Guidelines (39)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (22)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4744)
  2. Department of Medicine (4742)
  3. Center for Pancreatic Cancer Research (2312)
  4. Surgery (1065)
  5. Survivorship Research (1013)
  6. Epidemiology and Biostatistics (842)

More Groups

People
  1. Eileen O'Reilly (803)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (219)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (147)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (320)
  5. American Association for Cancer Research (281)
  6. Wiley Blackwell (241)

More Publishers

Results (4744)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Circulating KRAS variant-specific shedding and association with survival in patients with metastatic pancreatic ductal adenocarcinoma (mPDAC) receiving chemoimmunotherapy
    Meeting Abstract

    Till, J. E.; McDaniel, L.; Pfeiffer, S. M.; Maurer, D. M.; Yu, J.; Spencer, C.; Lyman, J. P.; Cabanski, C. R.; Da Silva, D. M.; Abbott, C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Development of Memorial Sloan Kettering (MSK) surgery stress score for older adults with cancer
    Meeting Abstract

    Shahrokni, A.; Tin, A. L.; Downey, R. J.; Bochner, B. H.; Nash, G. M.; Kim, S. J.; Afonso, A.; Korc-Grodzicki, B.; Vickers, A.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Efficacy and safety of zenocutuzumab, a HER2 x HER3 bispecific antibody, across advanced NRG1 fusion (NRG1+) cancers
    Meeting Abstract

    Schram, A. M.; Goto, K.; Kim, D. W.; Martin-Romano, P.; Ou, S. H. I.; O'Kane, G. M.; O'Reilly, E. M.; Umemoto, K.; Duruisseaux, M.; Neuzillet, C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Patient-reported outcomes from the phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
    Meeting Abstract

    Sangro, B.; Galle, P. R.; Kelley, R. K.; Charoentum, C.; De Toni, E. N.; Ostapenko, Y.; Heo, J.; Cheng, A. L.; Vogel, A.; Marcovitz, M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • FORTITUDE: Results of a phase 1a study of the novel transgene-armed and tumor-selective vector NG-350A with and without pembrolizumab (pembro)
    Meeting Abstract

    Rosen, L. S.; Camidge, D. R.; Khalil, D.; Lillie, T.; Carter, J.; Krige, D.; Davies, J.; Miles, D.; Patel, M.; Evilevitch, V.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • First-in-human phase 1 trial of ELI-002 immunotherapy as treatment for subjects with Kirsten rat sarcoma (KRAS)-mutated pancreatic ductal adenocarcinoma and other solid tumors
    Meeting Abstract

    Pant, S.; Furqan, M.; Abdul-Karim, R. M.; Chung, V.; Devoe, C. E.; Johnson, M. L.; Leal, A. D.; Park, H.; Wainberg, Z. A.; Welkowsky, E.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Zolbetuximab plus gemcitabine and nab-paclitaxel (GN) in first-line treatment of claudin 18.2-positive metastatic pancreatic cancer (mPC): Phase 2, open-label, randomized study
    Meeting Abstract

    Park, W.; O'Reilly, E. M.; Furuse, J.; Li, C. P.; Oh, D. Y.; Garcia-Carbonero, R.; Roth, G.; Lee, H. J.; Kunieda, F.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Immunogenomic characterization of biliary tract cancers: Biomarker enrichment for benefit to immune checkpoint blockade
    Meeting Abstract

    Park, W.; Keane, F.; Bandlamudi, C.; Donoghue, M.; de Lara, P. T.; Harding, J. J.; Khalil, D.; McKinnell, Z.; Sterpi, M.; Cao, W.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Distinct biosignatures associate with survival after chemoimmunotherapy in a randomized, three-arm phase II study in patients with metastatic pancreatic cancer
    Meeting Abstract

    Padrón, L. J.; Maurer, D. M.; O'Hara, M. H.; O'Reilly, E. M.; Wolff, R. A.; Wainberg, Z. A.; Ko, A. H.; Fisher, G. A.; Rahma, O. E.; Lyman, J. P.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase III study (daNIS-2) of the anti-TGF-β monoclonal antibody (mAb) NIS793 with nab-paclitaxel/gemcitabine (NG) versus NG alone in patients (pts) with first-line metastatic pancreatic ductal adenocarcinoma (mPDAC)
    Meeting Abstract

    O'Reilly, E. M.; Golan, T.; Ikeda, M.; Milella, M.; Taieb, J.; Wainberg, Z. A.; Wang, L. W.; Gyambibi, N.; Lopez-Martin, E. M.; Xu, K.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save